Key result
Cost-effective CVD interventions in developing countries are projected to save ~24 million lives.
Cost-effective cardiovascular health promotion and prevention strategies in developing countries have the potential to save millions of lives and significantly reduce economic burdens.
Cost-effective interventions may avert 24 million CVD deaths and $8 billion in costs in developing countries; leaves open the need for targeted implementation studies.
Cardiovascular disease (CVD) is the number one cause of mortality world-wide and places a high medical and socioeconomic burden on developing countries. Our understanding of CVD and its evolution over the last 100 years has altered considerably. Reasons for the increased rate of CVD in the developing world include rapid urbanization and the demographic shift known as the modern epidemiologic transition. The case for intervention is based on both major human and economic impacts of CVD. It has been estimated that cost-effective interventions in developing countries with a high burden of CVD could result in a projected 24 million lives saved. This reduction in CVD mortality could reduce economic costs by $8 billion. Approaches to intervention include: 1) cardiovascular health promotion and CVD prevention and 2) action plans advocated by the World Health Organization.
No takes yet. Share an insight, caveat, or question.
Estel et al. (2016) conducted a review in Cardiovascular disease. Cost-effective interventions for cardiovascular disease in developing countries could save a projected 24 million lives and reduce economic costs by $8 billion.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: